A drug delivery technology that ‘shuttles’ molecules across the blood-brain-barrier could have major implications in developing drugs for disorders such as Alzheimer's and Parkinson’s disease, Roche says.
Non-profit epilepsy research sponsor, Epilepsy Therapy Project (ETP), has announced it is to invest in central nervous system (CNS) drug delivery specialist, ICVrx, to support the development of novel drug tech designed to tackle refractory epilepsy.
A nanoparticle-based delivery system is being developed in the UK
as a potential means of bypassing the blood brain barrier and
improve the treatment of central nervous system diseases such as
A novel technology set to overcome the challenges of the blood
brain barrier is being developed in a bid to open the gates to
previously unusable compounds for the treatment of central nervous
system (CNS) disorders.
Researchers believe that new treatments or ways to diagnose memory
problems will get a boost from a substantial grant that aims to
create a brain-scanning method to test drug treatments, which
investigates how brain cells age, and...
Efforts to improve the efficacy of cancer therapy by blocking
cellular mechanisms that underlie resistance to cytotoxic drugs
have promised much but delivered little to date. Now, a team of
researchers in the US believe they have...
New research in the US, focusing on the pharmacological aspects of
smoking marijuana, are closer to understanding how the drugs active
ingredients exert its effects, paving the way for drugs that
selectively bind and block subtypes...
Researchers have developed the first tool to identify and study
individual neurons activated in a living animal, ultimately leading
to the development of targeted drugs that directly affect neurons
involved in neurological diseases...